PAA Post AGM ,, 2022 Highlights, page-117

Did anyone else notice RA's comment about "if PAA's manufacture of MPL was better than Elanco's?" ? This sounded to me like it may be the sticking point of a current deal. I wonder therefore if this is the extra work that Epichem is doing with MPL for PAA? Maybe working out if there are any slight variations in the way the MPL has been made which may affect how it works in dogs/humans? Elanco would want to use its own manufacturing for MPL so needs to be confident that it will work in the same way. Just a thought !
The comment was made by RA in response to the question re if a deal maybe done before the phase 2 is complete.